These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 24792688)
21. Seed displacements after permanent brachytherapy for prostate cancer in dependence on the prostate level. Pinkawa M; Gagel B; Asadpour B; Piroth MD; Klotz J; Borchers H; Jakse G; Eble MJ Strahlenther Onkol; 2008 Oct; 184(10):520-5. PubMed ID: 19016041 [TBL] [Abstract][Full Text] [Related]
22. Prostate volume contouring: a 3D analysis of segmentation using 3DTRUS, CT, and MR. Smith WL; Lewis C; Bauman G; Rodrigues G; D'Souza D; Ash R; Ho D; Venkatesan V; Downey D; Fenster A Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1238-47. PubMed ID: 17336224 [TBL] [Abstract][Full Text] [Related]
23. Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy. Stone NN; Hong S; Lo YC; Howard V; Stock RG Brachytherapy; 2003; 2(1):17-25. PubMed ID: 15062159 [TBL] [Abstract][Full Text] [Related]
24. Role of transrectal ultrasonography in prostate brachytherapy. Ellis WJ J Endourol; 2000 May; 14(4):329-35. PubMed ID: 10910148 [TBL] [Abstract][Full Text] [Related]
25. [Imaging of the abdominal wall: combination of tissue-harmonic-imaging and extended field-of-view sonography]. Mahnken AH; Krombach GA; Hohl C; Heussen N; Truong S; Guenther RW Rofo; 2004 Dec; 176(12):1837-42. PubMed ID: 15573297 [TBL] [Abstract][Full Text] [Related]
26. [Dosimetric evaluation of interstitial high-dose-rate implants for localised prostate cancer]. Fröhlich G; Agoston P; Lövey J; Somogyi A; Fodor J; Major T Magy Onkol; 2007; 51(1):31-8. PubMed ID: 17417673 [TBL] [Abstract][Full Text] [Related]
27. Anatomic limitations of prostatic urethra in using cylindrical stents. Milroy EJ; Rickards D J Endourol; 1997 Dec; 11(6):455-8. PubMed ID: 9440856 [TBL] [Abstract][Full Text] [Related]
28. "State of the art" transrectal ultrasound imaging in the assessment of prostatic disease. Clements R; Griffiths GJ; Peeling WB Br J Radiol; 1991 Mar; 64(759):193-200. PubMed ID: 1708687 [No Abstract] [Full Text] [Related]
29. Ultrasound-planned high-dose-rate prostate brachytherapy: dose painting to the dominant intraprostatic lesion. Crook J; Ots A; Gaztañaga M; Schmid M; Araujo C; Hilts M; Batchelar D; Parker B; Bachand F; Milette MP Brachytherapy; 2014; 13(5):433-41. PubMed ID: 24958556 [TBL] [Abstract][Full Text] [Related]
30. High-dose-rate prostate brachytherapy consistently results in high quality dosimetry. White EC; Kamrava MR; Demarco J; Park SJ; Wang PC; Kayode O; Steinberg ML; Demanes DJ Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):543-8. PubMed ID: 22652111 [TBL] [Abstract][Full Text] [Related]
31. A novel method for accurate needle-tip identification in trans-rectal ultrasound-based high-dose-rate prostate brachytherapy. Zheng D; Todor DA Brachytherapy; 2011; 10(6):466-73. PubMed ID: 21549646 [TBL] [Abstract][Full Text] [Related]
32. Comparison of real-time intraoperative ultrasound-based dosimetry with postoperative computed tomography-based dosimetry for prostate brachytherapy. Nag S; Shi P; Liu B; Gupta N; Bahnson RR; Wang JZ Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):311-7. PubMed ID: 17996395 [TBL] [Abstract][Full Text] [Related]
33. The nature and extent of urinary morbidity in relation to prostate brachytherapy urethral dosimetry. Neill M; Studer G; Le L; McLean M; Yeung I; Pond G; Crook JM Brachytherapy; 2007; 6(3):173-9. PubMed ID: 17681239 [TBL] [Abstract][Full Text] [Related]
34. Urethra low-dose tunnels: validation of and class solution for generating urethra-sparing dose plans using inverse planning simulated annealing for prostate high-dose-rate brachytherapy. Cunha JA; Pouliot J; Weinberg V; Wang-Chesebro A; Roach M; Hsu IC Brachytherapy; 2012; 11(5):348-53. PubMed ID: 21937284 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of prostate volume by transrectal ultrasonography for use in a brachytherapy program. Chenven ES; Glazier DB; Krisch EB; Diamond SM; Marmar JL Urology; 2001 Nov; 58(5):752-5. PubMed ID: 11711354 [TBL] [Abstract][Full Text] [Related]
36. 3-D conformal HDR brachytherapy as monotherapy for localized prostate cancer. A pilot study. Martin T; Baltas D; Kurek R; Röddiger S; Kontova M; Anagnostopoulos G; Dannenberg T; Buhleier T; Skazikis G; Tunn U; Zamboglou N Strahlenther Onkol; 2004 Apr; 180(4):225-32. PubMed ID: 15057433 [TBL] [Abstract][Full Text] [Related]
37. Do differences in target volume definition in prostate cancer lead to clinically relevant differences in normal tissue toxicity? Livsey JE; Wylie JP; Swindell R; Khoo VS; Cowan RA; Logue JP Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1076-81. PubMed ID: 15519777 [TBL] [Abstract][Full Text] [Related]
39. Is the use of a surrogate urethra an option in prostate high-dose-rate brachytherapy? Nilsson J; Kälkner KM; Berg L; Levitt S; Holmberg C; Nilsson S; Lundell M Int J Radiat Oncol Biol Phys; 2008 May; 71(1):36-40. PubMed ID: 17980507 [TBL] [Abstract][Full Text] [Related]
40. A comparative study of seed localization and dose calculation on pre- and post-implantation ultrasound and CT images for low-dose-rate prostate brachytherapy. Ali I; Algan O; Thompson S; Sindhwani P; Herman T; Cheng CY; Ahmad S Phys Med Biol; 2009 Sep; 54(18):5595-611. PubMed ID: 19717887 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]